CLL Society

WHAT’S NEW

May 26, 2022

Your connection to the most current news, information, and data about Chronic Lymphocytic Leukemia.

We suggest you BOOKMARK this page and visit it often. All content was current as of the date it was published.
In science and in medicine, information is constantly changing. Published content may become out-of-date as new information and data emerge.

COVID-19 Updates

Living with CLL

Christina Rodriguez Fuller – Patient

I was diagnosed in October 2018. My journey led me to a local hematologist, then a CLL specialist in Houston before settling with a CLL specialist in Dallas where I participated in the ECOG trial.

SPECIAL FEATURE: Registration is Live for Celebrating Long Lives

Registration is officially open for our inaugural, virtual Celebrating Long Lives 5K Walk/Run event! Join us on July 23rd to recognize, support, and raise awareness of those who have been touched by a chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) diagnosis.

We encourage everyone who participates to become a fundraiser for the mission of CLL Society and help us raise $10,000 to provide CLL/SLL patients and caregivers the support and education they need to conquer their diagnosis.

Register by June 30th to receive your event t-shirt before event day. We are all in this together; so let’s all do this together!

Learn More and Register Now!

UPCOMING EVENTS

The Evolving Role of BTKi’s in CLL
Tuesday, June 28th at 10 AM PT / 1 PM ET

The targeted therapy Bruton tyrosine kinase inhibitors (BTKi’s) have come a long way since revolutionizing CLL treatment with the arrival of ibrutinib. Join CLL Society and Dr. Matthew Davids from Dana Farber Cancer Institute to take a deep dive into different BTKi’s, how they work, how they compare to each other and other treatment options, potential side effects, and the future role of these therapies.

Register Now

On-Demand Replay

If you missed the May 16th CLL Society webinar, Is a Clinical Trial Right for You?, you can watch the replay here.

Treatment Updates

Equitable Access and Regulatory News